PT1627645T - Agente antitumoral e processo para a sua produção - Google Patents
Agente antitumoral e processo para a sua produçãoInfo
- Publication number
- PT1627645T PT1627645T PT47072954T PT04707295T PT1627645T PT 1627645 T PT1627645 T PT 1627645T PT 47072954 T PT47072954 T PT 47072954T PT 04707295 T PT04707295 T PT 04707295T PT 1627645 T PT1627645 T PT 1627645T
- Authority
- PT
- Portugal
- Prior art keywords
- producing
- same
- antitumor agent
- antitumor
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003147852 | 2003-05-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1627645T true PT1627645T (pt) | 2017-11-23 |
Family
ID=33475378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT47072954T PT1627645T (pt) | 2003-05-26 | 2004-02-02 | Agente antitumoral e processo para a sua produção |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7682630B2 (pt) |
| EP (1) | EP1627645B1 (pt) |
| JP (1) | JP4669393B2 (pt) |
| CN (1) | CN1697663A (pt) |
| AU (1) | AU2004241830B9 (pt) |
| CA (1) | CA2489259C (pt) |
| ES (1) | ES2642179T3 (pt) |
| HU (1) | HUE035003T2 (pt) |
| PT (1) | PT1627645T (pt) |
| TW (1) | TW200505414A (pt) |
| WO (1) | WO2004103409A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006238072A1 (en) * | 2005-04-18 | 2006-10-26 | Hiroshi Maeda | Polymeric pharmaceutical agent for treatment of cancer and process for production of the same |
| ES2357325T3 (es) * | 2005-09-12 | 2011-04-25 | Yogesh Bendale. N | Platino biológico novedoso, procedimiento de preparación, procedimiento de administración para tratamiento antitumoral. |
| FR2922452B1 (fr) * | 2007-10-19 | 2010-01-22 | Coatex Sas | Formulations de composes organoplatiniques en presence de polymeres associatifs, produits obtenus et leurs utilisations |
| JP2010013411A (ja) * | 2008-07-05 | 2010-01-21 | Hiroshi Maeda | 抗炎症剤 |
| EP2774625B1 (en) | 2011-09-05 | 2017-04-12 | Hiroshi Maeda | Polymer-type fluorescent molecule probe |
| JP6083738B2 (ja) * | 2013-03-06 | 2017-02-22 | 公立大学法人大阪市立大学 | ホウ素中性子捕捉療法用組成物およびその製造方法 |
| JP6564369B2 (ja) | 2013-12-09 | 2019-08-21 | デュレクト コーポレイション | 薬学的活性剤複合体、ポリマー複合体、ならびにこれらを伴う組成物及び方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3367921D1 (en) * | 1982-02-27 | 1987-01-15 | Kuraray Co | Neocarzinostatin complexes, a method for producing the same, and an antitumor agent containing said complexes as an active component |
| JPS58149903A (ja) * | 1982-02-27 | 1983-09-06 | Kuraray Co Ltd | ネオカルチノスタチン複合体の製造法 |
| JPS6075499A (ja) * | 1983-08-08 | 1985-04-27 | Kuraray Co Ltd | ネオカルチノスタチン誘導体及びその製造法 |
| JP2556865B2 (ja) * | 1986-09-19 | 1996-11-27 | 山之内製薬株式会社 | ネオカルチノスタチン誘導体の非注射投与用組成物 |
| US5281710A (en) * | 1990-08-01 | 1994-01-25 | The Scripps Research Institute | Dynemicin analogs: synthesis, methods of preparation and use |
| ES2151277T3 (es) * | 1996-05-22 | 2000-12-16 | Protarga Inc | Composiciones que comprenden conjugados de acido cis-docosahexaenoico y taxotere. |
| GB0001481D0 (en) * | 2000-01-21 | 2000-03-15 | Theryte Ltd | System for delivering a medicament |
| KR100446101B1 (ko) | 2000-12-07 | 2004-08-30 | 주식회사 삼양사 | 수난용성 약물의 서방성 제형 조성물 |
-
2004
- 2004-02-02 AU AU2004241830A patent/AU2004241830B9/en not_active Expired
- 2004-02-02 WO PCT/JP2004/000993 patent/WO2004103409A1/ja active Application Filing
- 2004-02-02 EP EP04707295.4A patent/EP1627645B1/en not_active Expired - Fee Related
- 2004-02-02 HU HUE04707295A patent/HUE035003T2/en unknown
- 2004-02-02 CA CA2489259A patent/CA2489259C/en not_active Expired - Fee Related
- 2004-02-02 US US10/514,892 patent/US7682630B2/en not_active Expired - Fee Related
- 2004-02-02 JP JP2005506303A patent/JP4669393B2/ja not_active Expired - Fee Related
- 2004-02-02 CN CNA2004800006708A patent/CN1697663A/zh active Pending
- 2004-02-02 ES ES04707295.4T patent/ES2642179T3/es not_active Expired - Lifetime
- 2004-02-02 PT PT47072954T patent/PT1627645T/pt unknown
- 2004-03-15 TW TW093106868A patent/TW200505414A/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TW200505414A (en) | 2005-02-16 |
| AU2004241830B2 (en) | 2010-02-25 |
| EP1627645A4 (en) | 2008-12-24 |
| EP1627645A1 (en) | 2006-02-22 |
| CN1697663A (zh) | 2005-11-16 |
| AU2004241830B9 (en) | 2010-04-22 |
| JPWO2004103409A1 (ja) | 2006-07-20 |
| AU2004241830A1 (en) | 2004-12-02 |
| EP1627645B1 (en) | 2017-08-23 |
| CA2489259C (en) | 2011-08-30 |
| CA2489259A1 (en) | 2004-12-02 |
| US20050208136A1 (en) | 2005-09-22 |
| ES2642179T3 (es) | 2017-11-15 |
| WO2004103409A1 (ja) | 2004-12-02 |
| HUE035003T2 (en) | 2018-05-02 |
| JP4669393B2 (ja) | 2011-04-13 |
| TWI332834B (pt) | 2010-11-11 |
| US7682630B2 (en) | 2010-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1085489A1 (en) | Chitosan-containing polyaccharide, process for producing the same and use thereof | |
| AU2003257604A8 (en) | Stent and process for producing the same | |
| EP1783096A4 (en) | ALPHA-SIALON POWDER AND PROCESS FOR PRODUCING THE SAME | |
| EP1746080A4 (en) | 1,6-SUBSTITUTED 3,8-DIHALOGENOPYRENE AND METHOD FOR THE PRODUCTION THEREOF | |
| HK1092101A1 (en) | Fine-grain silver powder and process for producing the same | |
| AU2003248074A8 (en) | Composite nanoparticle and process for producing the same | |
| EP1646023A4 (en) | SAFETY STICKER AND PROCESS FOR ITS MANUFACTURE | |
| EP1550688A4 (en) | ORGANOPOLYSILOXANE-MODIFIED POLYSACCHARIDE AND PROCESS FOR PRODUCING THE SAME | |
| HK1100873A1 (en) | Candy and process for producing the same | |
| HK1093485A1 (en) | Compound having anti-hcv activity and process for producing the same | |
| GB2421005B (en) | Fibrous laminate and process for producing the same | |
| EP1521760A4 (en) | N-ACETYL-D-GLUCOSAMINE AND METHOD FOR PREPARING N-ACETYL-D-GLUCOSAMINE | |
| EP1640006A4 (en) | PARTICLES WITH DELAYED MEDICAMENT RELIEF AND MANUFACTURING METHOD THEREFOR | |
| EP1651018A4 (en) | SUBSTRATE AND METHOD FOR PRODUCING THE SAME | |
| HK1087893A1 (en) | Masticatable capsule and process for producing the same | |
| GB2418856B (en) | Breath freshener and process for producing the same | |
| EP1719776A4 (en) | SILICON COMPOUND AND PROCESS FOR PRODUCING THE SAME | |
| EP1514870A4 (en) | PRODRUG AND METHOD FOR THE PRODUCTION THEREOF | |
| SI1663669T1 (sl) | Dekorativni laminat in postopek za njegovo izdelavo | |
| EP1627645A4 (en) | ANTITUMMER AGENT AND METHOD FOR PRODUCING THE SAME | |
| IL180988A0 (en) | Antiplatelet agent and process for producing the same | |
| EP1667174A4 (en) | SUPERCONDUCTOR AND METHOD FOR PRODUCING THE SAME | |
| EP1757388A4 (en) | SURFACE-COATED CUTTING TOOL AND METHOD OF MANUFACTURING THE SAME | |
| EP1544276A4 (en) | ANTIOXIDANE AND ITS PRODUCTION | |
| EP1637864A4 (en) | Disintegrators for the chro- matography and associated preparation method |